Page last updated: 2024-08-16

mitomycin and mk-1775

mitomycin has been researched along with mk-1775 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, T; Hirai, H; Imagaki, K; Iwasawa, Y; Kobayashi, M; Kotani, H; Mizuarai, S; Nishibata, T; Ohtani, J; Okada, M; Sakai, N; Sakai, T; Yoshizumi, T1
Brody, JR; Chand, SN; Dylgjeri, E; Lal, S; Mambelli-Lisboa, NC; Pishvaian, MJ; Winter, JM; Yeo, CJ; Zarei, M1

Other Studies

2 other study(ies) available for mitomycin and mk-1775

ArticleYear
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.
    Cancer biology & therapy, 2010, Apr-01, Volume: 9, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Capecitabine; Caspases; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; DNA Damage; Doxorubicin; Flow Cytometry; Fluorouracil; Glutamates; Guanine; Histones; Humans; Immunoenzyme Techniques; Mitomycin; Nuclear Proteins; Pemetrexed; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Rats; Rats, Inbred F344; Rats, Nude; Xenograft Model Antitumor Assays

2010
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.
    Scientific reports, 2016, 09-12, Volume: 6

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Drug Synergism; Humans; Inhibitory Concentration 50; Mitomycin; Mitosis; Mutagens; Mutation; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones

2016